CorVista Health Completes $65 Million Series C Equity Raise Bringing Total Funding to Nearly $100 Million Funding to Fuel Development and Commercialization Efforts for Non-Invasive Diagnostic System to Assess for Heart Disease TORONTO, ON, March 4, 2021 — CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, today announced it has closed a $65 million Series C equity financing. This latest financing round brings the total cash raised to nearly $100 million. This significant capital infusion provides a runway for ongoing research, development and commercialization efforts for CorVista® System, the company’s non-invasive, point-of-care solution that allows physicians to rapidly test for heart disease. “There has never been a more critical need for point-of-care diagnostic modalities that provide rapid testing for cardiac patients,” said Don Crawford, Chief Executive Officer. “We believe the CorVista Sys